GlaxoSmithKline
- Country
- π¬π§United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years Old
- Conditions
- AIDS
- Interventions
- Biological: HIV Vaccine 732462Biological: Placebo vaccine
- First Posted Date
- 2008-12-25
- Last Posted Date
- 2018-06-18
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 41
- Registration Number
- NCT00814762
- Locations
- π©πͺ
GSK Investigational Site, Hamburg, Germany
Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults
- Conditions
- Streptococcus PneumoniaeHaemophilus Influenzae
- Interventions
- Biological: GSK2231395ABiological: Engerix-B
- First Posted Date
- 2008-12-25
- Last Posted Date
- 2018-08-08
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 40
- Registration Number
- NCT00814489
- Locations
- πΈπͺ
GSK Investigational Site, Karlskrona, Sweden
A Clinical Trial to Test a Study Drug in Volunteers Who Develop Asthma Following Exercise
- First Posted Date
- 2008-12-22
- Last Posted Date
- 2017-09-19
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 47
- Registration Number
- NCT00812929
- Locations
- πΊπΈ
GSK Investigational Site, El Paso, Texas, United States
Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)
- Conditions
- Depressive Disorder
- Interventions
- First Posted Date
- 2008-12-22
- Last Posted Date
- 2017-01-13
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 56
- Registration Number
- NCT00812812
- Locations
- π―π΅
GSK Investigational Site, Tokyo, Japan
Study to Evaluate GSK2190915 in Subjects With Mild Asthma
- First Posted Date
- 2008-12-22
- Last Posted Date
- 2016-10-12
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 17
- Registration Number
- NCT00812773
- Locations
- π¬π§
GSK Investigational Site, Manchester, United Kingdom
A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine.
- Conditions
- Influenza
- Interventions
- Biological: GSK1562902A
- First Posted Date
- 2008-12-22
- Last Posted Date
- 2018-08-20
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 320
- Registration Number
- NCT00812981
- Locations
- π¨π³
GSK Investigational Site, Taipei, Taiwan
Safety Study of GSK Biologicals' HPV Vaccine (GSK-580299) in Healthy Female Subjects.
- Conditions
- Infections, Papillomavirus
- Interventions
- Biological: Cervarix
- First Posted Date
- 2008-12-19
- Last Posted Date
- 2016-10-20
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 92
- Registration Number
- NCT00811798
- Locations
- ππ°
GSK Investigational Site, Hong Kong, Hong Kong
A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia
- Conditions
- Waldenstrom Macroglobulinaemia
- Interventions
- Biological: Ofatumumab
- First Posted Date
- 2008-12-19
- Last Posted Date
- 2017-05-30
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 37
- Registration Number
- NCT00811733
- Locations
- πΊπΈ
GSK Investigational Site, San Antonio, Texas, United States
A First Time in Human Study in Healthy Volunteers to Investigate a New Medicine to Treat Malaria
- First Posted Date
- 2008-12-19
- Last Posted Date
- 2017-08-03
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 12
- Registration Number
- NCT00811356
- Locations
- π¦πΊ
GSK Investigational Site, Melbourne, Victoria, Australia
Repeat Dose Food Effect Study of GSK256073F in Healthy Adult Subjects
- First Posted Date
- 2008-12-15
- Last Posted Date
- 2017-06-05
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 30
- Registration Number
- NCT00808093
- Locations
- πΊπΈ
GSK Investigational Site, Baltimore, Maryland, United States